Cwm, LLC Viridian Therapeutics, Inc.\De Transaction History
Cwm, LLC
- $28.4 Billion
- Q2 2025
A detailed history of Cwm, LLC transactions in Viridian Therapeutics, Inc.\De stock. As of the latest transaction made, Cwm, LLC holds 427 shares of VRDN stock, worth $7,540. This represents 0.0% of its overall portfolio holdings.
Number of Shares
427
Previous 234
82.48%
Holding current value
$7,540
Previous $3,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding VRDN
# of Institutions
187Shares Held
79.7MCall Options Held
92.2KPut Options Held
55.2K-
Deep Track Capital, LP Greenwich, CT5.38MShares$95 Million2.54% of portfolio
-
Black Rock Inc. New York, NY4.77MShares$84.3 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ4.7MShares$83 Million5.34% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.56MShares$80.6 Million0.0% of portfolio
-
Vr Adviser, LLC New York, NY3.88MShares$68.6 Million12.64% of portfolio
About Viridian Therapeutics, Inc.\DE
- Ticker VRDN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,888,900
- Market Cap $704M
- Description
- Viridian Therapeutics, Inc., a biotechnology company, develops treatments for patients suffering from serious diseases. It develops VRDN-001, a humanized monoclonal anti-IGF-1R antibody that is in Phase 1/2 clinical trial for the treatment of thyroid eye disease (TED); VRDN-002, an IGF-1R antibody, which is in Phase 1 clinical trial; and VRDN-00...